357 related articles for article (PubMed ID: 23720576)
21. Estradiol and raloxifene as adjunctive treatment for women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Li Z; Wang Y; Wang Z; Kong L; Liu L; Li L; Tang Y
Acta Psychiatr Scand; 2023 Apr; 147(4):360-372. PubMed ID: 36585771
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and Acceptability of Cariprazine in Acute Exacerbation of Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials.
Zhao MJ; Qin B; Wang JB; Zhang YP; Zhao JT; Mao YG; Zhang XY; Zhang RL
J Clin Psychopharmacol; 2018 Feb; 38(1):55-59. PubMed ID: 29257786
[TBL] [Abstract][Full Text] [Related]
23. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
Kulkarni J; Gavrilidis E; Gwini SM; Worsley R; Grigg J; Warren A; Gurvich C; Gilbert H; Berk M; Davis SR
JAMA Psychiatry; 2016 Sep; 73(9):947-54. PubMed ID: 27438995
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders - A comprehensive systematic review and meta-analysis.
Jeppesen R; Christensen RHB; Pedersen EMJ; Nordentoft M; Hjorthøj C; Köhler-Forsberg O; Benros ME
Brain Behav Immun; 2020 Nov; 90():364-380. PubMed ID: 32890697
[TBL] [Abstract][Full Text] [Related]
25. Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials.
Zheng W; Cai DB; Zhang QE; He J; Zhong LY; Sim K; Ungvari GS; Ning YP; Xiang YT
J Psychiatr Res; 2019 Jun; 113():27-33. PubMed ID: 30878789
[TBL] [Abstract][Full Text] [Related]
26. Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.
Lane HY; Chang YC; Liu YC; Chiu CC; Tsai GE
Arch Gen Psychiatry; 2005 Nov; 62(11):1196-204. PubMed ID: 16275807
[TBL] [Abstract][Full Text] [Related]
27. Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis.
Demyttenaere K; Detraux J; Racagni G; Vansteelandt K
CNS Drugs; 2019 Jun; 33(6):549-566. PubMed ID: 31065941
[TBL] [Abstract][Full Text] [Related]
28. Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
Correll CU; Maayan L; Kane J; Hert MD; Cohen D
J Clin Psychiatry; 2016 Jun; 77(6):e746-56. PubMed ID: 27337425
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan.
Kishi T; Ikuta T; Sakuma K; Okuya M; Iwata N
J Psychiatr Res; 2021 Jun; 138():444-452. PubMed ID: 33964682
[TBL] [Abstract][Full Text] [Related]
30. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial.
Brown HE; Freudenreich O; Fan X; Heard SO; Goff D; Petrides G; Harrington AL; Kane JM; Judge H; Hoeppner B; Fava M; Perlis RH
JAMA Psychiatry; 2019 Jul; 76(7):691-699. PubMed ID: 30916714
[TBL] [Abstract][Full Text] [Related]
32. Blonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trials.
Kishi T; Matsuda Y; Nakamura H; Iwata N
J Psychiatr Res; 2013 Feb; 47(2):149-54. PubMed ID: 23131856
[TBL] [Abstract][Full Text] [Related]
33. Association of End Point Definition and Randomized Clinical Trial Duration in Clinical Trials of Schizophrenia Medications.
Younis IR; Gopalakrishnan M; Mathis M; Mehta M; Uppoor R; Zhu H; Farchione T
JAMA Psychiatry; 2020 Oct; 77(10):1064-1071. PubMed ID: 32609294
[TBL] [Abstract][Full Text] [Related]
34. Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review.
Kishi T; Mukai T; Matsuda Y; Iwata N
Neuromolecular Med; 2014 Mar; 16(1):61-9. PubMed ID: 23896722
[TBL] [Abstract][Full Text] [Related]
35. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
Kane JM; Correll CU; Goff DC; Kirkpatrick B; Marder SR; Vester-Blokland E; Sun W; Carson WH; Pikalov A; Assunção-Talbott S
J Clin Psychiatry; 2009 Oct; 70(10):1348-57. PubMed ID: 19906340
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia.
Singh SP; Singh V
CNS Drugs; 2011 Oct; 25(10):859-85. PubMed ID: 21936588
[TBL] [Abstract][Full Text] [Related]
37. Statin add-on therapy in the antipsychotic treatment of schizophrenia: A meta-analysis.
Nomura I; Kishi T; Ikuta T; Iwata N
Psychiatry Res; 2018 Feb; 260():41-47. PubMed ID: 29172097
[TBL] [Abstract][Full Text] [Related]
38. Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials.
Cho M; Lee TY; Kwak YB; Yoon YB; Kim M; Kwon JS
Aust N Z J Psychiatry; 2019 Aug; 53(8):742-759. PubMed ID: 30864461
[TBL] [Abstract][Full Text] [Related]
39. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
[TBL] [Abstract][Full Text] [Related]
40. Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial.
Weiser M; Levi L; Zamora D; Biegon A; SanGiovanni JP; Davidson M; Burshtein S; Gonen I; Radu P; Slobozean Pavalache K; Nastas I; Hemi R; Ryan T; Davis JM
JAMA Psychiatry; 2019 Oct; 76(10):1009-1017. PubMed ID: 31365044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
